Previous close | 139.80 |
Open | N/A |
Bid | 157.00 |
Ask | 166.00 |
Strike | 580.00 |
Expiry date | 2025-01-17 |
Day's range | 139.80 - 139.80 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...